LifeSprout closes $28.5M Series A round
Apr 28, 2020
- No Comments
Company closed round that was led by investors from San Francisco and Baltimore, allowing the Johns Hopkins spin-out to continue clinical development of its first product. LifeSprout is a LaunchPort Resident that operates clean room, wet lab and engineering cells as part of their GMP process development efforts. News Article
Read More